Literature DB >> 8331699

Pulmonary biophysical effects of triiodothyronine augmentation during sepsis-induced hypothyroidism.

S A Dulchavsky1, S R Hendrick, S Dutta.   

Abstract

Sepsis may cause pulmonary dysfunction and altered metabolism; triiodothyronine (T3) replacement improves lung function and surfactant pool. We evaluated the biophysical effects of T3 replacement during sepsis-induced hypothyroidism. Male Holtzman rats underwent cecal ligation and puncture (CLP) or sham laparotomy (S); treatment was administered consisting of T3 (3 ng/h) or saline. Twenty-four hours after CLP, lungs were ventilation-perfused with oxygenated N-2-hydroxylpiperazine-N1-2-ethanesulfonic acid (HEPES) with 5 microCi 3-H choline (3-HC) for 1 hour. Perfusion pressures were continuously monitored; perfusate was monitored for 3-HC uptake and oxygen extraction. Triiodothyronine treatment abolished the sepsis-induced decrease in free T3 levels (S = 68 +/- 5 ng/dL, CLP < 15 ng/dL, CLP/T3 = 91 +/- 20 ng/dL). Lung wet-to-dry ratios and vascular and tracheal pressures were maintained by T3 treatment. Choline incorporation was not altered by sepsis or treatment. Triiodothyronine treatment reduced the sepsis-induced increase in oxygen requirement and improved septic pulmonary compromise through a nonhypermetabolic effect.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8331699     DOI: 10.1097/00005373-199307000-00017

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  4 in total

Review 1.  Nonthyroidal Illness Syndrome: To Treat or Not to Treat? Have We Answered the Question? A Review of Metanalyses.

Authors:  Salvatore Sciacchitano; Carlo Capalbo; Christian Napoli; Paolo Anibaldi; Valentina Salvati; Claudia De Vitis; Rita Mancini; Flaminia Coluzzi; Monica Rocco
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-10       Impact factor: 6.055

2.  Role of non-thyroidal illness syndrome in predicting adverse outcomes in COVID-19 patients predominantly of mild-to-moderate severity.

Authors:  David Tak Wai Lui; Chi Ho Lee; Wing Sun Chow; Alan Chun Hong Lee; Anthony Raymond Tam; Carol Ho Yi Fong; Chun Yiu Law; Eunice Ka Hong Leung; Kelvin Kai Wang To; Kathryn Choon Beng Tan; Yu Cho Woo; Ching Wan Lam; Ivan Fan Ngai Hung; Karen Siu Ling Lam
Journal:  Clin Endocrinol (Oxf)       Date:  2021-04-12       Impact factor: 3.523

3.  The Value of Decreased Thyroid Hormone for Predicting Mortality in Adult Septic Patients: A Systematic Review and Meta-Analysis.

Authors:  Jae Guk Kim; Hyungoo Shin; Wonhee Kim; Tae Ho Lim; Bohyoung Jang; Youngsuk Cho; Kyu-Sun Choi; Chiwon Ahn; Juncheol Lee; Min Kyun Na
Journal:  Sci Rep       Date:  2018-09-20       Impact factor: 4.379

4.  Thyroid dysfunction may be associated with poor outcomes in patients with COVID-19.

Authors:  Yan Zhang; Fengyu Lin; Wei Tu; Jianchu Zhang; Abira Afzal Choudhry; Omair Ahmed; Jun Cheng; Yanhui Cui; Ben Liu; Minhui Dai; Lingli Chen; Duoduo Han; Yifei Fan; Yanjun Zeng; Wen Li; Sha Li; Xiang Chen; Minxue Shen; Pinhua Pan
Journal:  Mol Cell Endocrinol       Date:  2020-12-02       Impact factor: 4.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.